Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

Industry & Investors Underestimate Clinical Trials Performances

Thu, 01/03/2019 - 9:58pm

Researchers from the MIT Laboratory for Financial Engineering, using clinical trials data provided by Informa Pharma Intelligence, have developed algorithms...

      Related Stories 

New Takeda R&D Collabs Aim To Boost IO Pipeline

Thu, 01/03/2019 - 7:21pm

In moves aimed at boosting its presence in the immuno-oncology field, Takeda unveils a series of new research collaborations it...

      Related Stories 

Verrica's Phase III Success Paves Way For Filing Of New Cantharidin Formulation VP-102

Thu, 01/03/2019 - 2:41pm

After reporting positive pivotal data for VP-102 in the contagious skin disease molluscum, Verrica is looking forward to a 2020...

      Related Stories 

Biotech Sector Raises $23bn In Venture Capital In 2018

Thu, 01/03/2019 - 6:50am

While major biotech indices went south in 2018, VC enthusiasm for biotech remained bullish. Biotech companies raised a record $22.83bn...

      Related Stories 

Vectura Breathes Easy As It Enters Eventful 2019

Thu, 01/03/2019 - 6:24am

With a steady stream of royalties coming in from Flutiform and Ultibro and a decent pipeline of innovative respiratory drugs...

      Related Stories 

Executives On The Move: A Duo Of CFOs For Compass And Generation Bio, And At Alcon A Promotion In Japan

Thu, 01/03/2019 - 5:22am

Cancer, inflammation and autoimmune firm Compass Therapeutics adds a new CFO, as does gene therapy company Generation Bio. And Alcon...

      Related Stories 

Viela Adds Momentum To Burgeoning NMOSD Market With Pivotal Inebilizumab Results

Thu, 01/03/2019 - 2:28am

2019 could be the year when three drugs are approved for rare disease neuromyelitis optica, a previously untreatable condition. Viela...

      Related Stories 

MyoKardia Frames End Of Sanofi Partnership As A Bet On Itself

Wed, 01/02/2019 - 12:59pm

Biotech regains full rights to a pair of targeted therapies for heart diseases, but will bear full development costs. MyoKardia...

      Related Stories 

US Drug Pricing: What A Difference A Year Makes

Wed, 01/02/2019 - 10:50am

Drug makers were optimistic going into 2018 about the political climate and drug pricing environment, but the outlook is more...

      Related Stories 

China's Innovent Biologics Emerges As Immuno-Oncology Competitor With Sintilimab Approval

Wed, 01/02/2019 - 7:16am

Medicines regulators have cleared Innovent Biologics's anti-PD-1 therapy, sintilimab, for classical Hodgkin's lymphoma in China, where late-stage studies as a...

      Related Stories